Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited - Equity Research Report Executive Summary Company: Emcure Pharmaceuticals Limited NSE Symbol: EMCURE Sector: Pharmaceuticals Market Cap: ₹22,500 Cr (approx.) Current Price: ₹1,350 (as of January 2025) Rating: HOLD Target Price (5Y): ₹1,800-2,000 Emcure Pharmaceuticals is a research-driven pharmaceutical company with strong presence in women's healthcare, HIV/AIDS treatment, and biosimilars. The company went public in July 2024 with India's largest pharma IPO worth ₹1,952 crores. Company Overview Business Segments Branded Formulations (India) - 45% of revenue International Business - 35% of revenue API/CRAMS - 20% of revenue Key Therapeutic Areas Women's Healthcare (Gynecology & Fertility) HIV/AIDS Treatment Oncology Critical Care Biosimilars Manufacturing Facilities 13 manufacturing facilities across India WHO-GMP, US FDA, and EU-GMP approved facilities Capacity for tablets, capsules, injectables,...